1. Health Canada seizes unauthorised health products

   News item 04 March 2023 Pages: 1 - 1

2. HPRA safety update on COVID-19 vaccines up to January 2023

   News item 04 March 2023 Pages: 2 - 2

3. MHRA conducting review of pseudoephedrine-related PRES and RCVS

   News item 04 March 2023 Pages: 3 - 3

4. Precautions for amlodipine and nifedipine use in pregnancy updated in Japan

   News item 04 March 2023 Pages: 4 - 4

5. Tetracycline ophthalmic ointment: quality issues

   News item 04 March 2023 Pages: 5 - 5

6. Warning against use of Kobayashi Eyebon Eye Wash, Cool format

   News item 04 March 2023 Pages: 6 - 6

7. African countries report fewer AEFIs after COVID-19 vaccination than RoW

   Clinical study 04 March 2023 Pages: 7 - 7

8. Anti-angiogenesis-related AEs associated with VEGFR-TKI use in metastatic RCC

   Clinical study 04 March 2023 Pages: 8 - 8

9. JAK inhibitor adverse events of special interest with baracitinib

   Clinical study 04 March 2023 Pages: 9 - 9

10. JAK inhibitors: high risk of infectious disease in patients with RA

    Clinical study 04 March 2023 Pages: 10 - 10

11. Medicine-related Prevention of Future Death reports in the UK

    Clinical study 04 March 2023 Pages: 11 - 11

12. Novavax COVID-19 vaccine-related myocarditis/pericarditis

    Clinical study 04 March 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 04 March 2023 Pages: 13 - 13

14. Actinium-225-dotatoc

    Case report 04 March 2023 Pages: 14 - 14

15. Ad26.cov2-s/azd-1222

    Case report 04 March 2023 Pages: 15 - 15

16. Ad26.cov2-s/azd-1222/tozinameran

    Case report 04 March 2023 Pages: 16 - 16

17. Ad26.cov2-s/elasomeran/tozinameran

    Case report 04 March 2023 Pages: 17 - 17

18. Adalimumab/antibacterials/leflunomide

    Case report 04 March 2023 Pages: 18 - 18

19. Adalimumab/etanercept/infliximab

    Case report 04 March 2023 Pages: 19 - 19

20. Adalimumab/infliximab

    Case report 04 March 2023 Pages: 20 - 20

21. Adalimumab/methotrexate

    Case report 04 March 2023 Pages: 21 - 21

22. Adenosine/amiodarone/lidocaine

    Case report 04 March 2023 Pages: 22 - 22

23. Agalsidase-alfa/agalsidase-beta

    Case report 04 March 2023 Pages: 23 - 23

24. Albendazole/ciclosporin

    Case report 04 March 2023 Pages: 24 - 24

25. Albumin-human

    Case report 04 March 2023 Pages: 25 - 25

26. Alectinib

    Case report 04 March 2023 Pages: 26 - 26

27. Alectinib

    Case report 04 March 2023 Pages: 27 - 27

28. Alectinib/crizotinib

    Case report 04 March 2023 Pages: 28 - 28

29. Alemtuzumab

    Case report 04 March 2023 Pages: 29 - 29

30. Alpelisib/metformin

    Case report 04 March 2023 Pages: 30 - 30

31. Alteplase

    Case report 04 March 2023 Pages: 31 - 31

32. Alteplase/streptokinase/tenecteplase

    Case report 04 March 2023 Pages: 32 - 32

33. Aminolevulinic-acid

    Case report 04 March 2023 Pages: 33 - 33

34. Amisulpride/risperidone

    Case report 04 March 2023 Pages: 34 - 34

35. Amitriptyline

    Case report 04 March 2023 Pages: 35 - 35

36. Amitriptyline/paracetamol

    Case report 04 March 2023 Pages: 36 - 36

37. Amoxicillin

    Case report 04 March 2023 Pages: 37 - 37

38. Anakinra

    Case report 04 March 2023 Pages: 38 - 38

39. Anti-BCMA-anti-CD38-bispecific-chimeric-antigen-receptor-T-cell-therapy-Shengyan-Pharmaceutical-Technology/antineoplastics

    Case report 04 March 2023 Pages: 39 - 39

40. Anti-cd19-chimeric-antigen-receptor-t-cell-therapy-tianjin-mycure-medical-technology

    Case report 04 March 2023 Pages: 40 - 40

41. Antibacterials

    Case report 04 March 2023 Pages: 41 - 41

42. Antibacterials

    Case report 04 March 2023 Pages: 42 - 42

43. Antibacterials

    Case report 04 March 2023 Pages: 43 - 43

44. Antibacterials/dexamethasone/fluconazole

    Case report 04 March 2023 Pages: 44 - 44

45. Antibacterials/dexamethasone/sodium-chloride

    Case report 04 March 2023 Pages: 45 - 45

46. Anticoagulants/bosentan/tadalafil

    Case report 04 March 2023 Pages: 46 - 46

47. Antifungals/immunosuppressants

    Case report 04 March 2023 Pages: 47 - 47

48. Antihistamines/colchicine/COVID-19 vaccine

    Case report 04 March 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 04 March 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 04 March 2023 Pages: 50 - 50